Comparison of Dopamine and Norepinephrine in the Treatment of Shock
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Both dopamine and norepinephrine are recommended as first-line vasopressor agents in the treatment of shock. There is a continuing controversy about whether one agent is superior to the other. METHODS: In this multicenter, randomized trial, we assigned patients with shock to receive either dopamine or norepinephrine as first-line vasopressor therapy to restore and maintain blood pressure. When blood pressure could not be maintained with a dose of 20 microg per kilogram of body weight per minute for dopamine or a dose of 0.19 microg per kilogram per minute for norepinephrine, open-label norepinephrine, epinephrine, or vasopressin could be added. The primary outcome was the rate of death at 28 days after randomization; secondary end points included the number of days without need for organ support and the occurrence of adverse events. RESULTS: The trial included 1679 patients, of whom 858 were assigned to dopamine and 821 to norepinephrine. The baseline characteristics of the groups were similar. There was no significant between-group difference in the rate of death at 28 days (52.5% in the dopamine group and 48.5% in the norepinephrine group; odds ratio with dopamine, 1.17; 95% confidence interval, 0.97 to 1.42; P=0.10). However, there were more arrhythmic events among the patients treated with dopamine than among those treated with norepinephrine (207 events [24.1%] vs. 102 events [12.4%], P<0.001). A subgroup analysis showed that dopamine, as compared with norepinephrine, was associated with an increased rate of death at 28 days among the 280 patients with cardiogenic shock but not among the 1044 patients with septic shock or the 263 with hypovolemic shock (P=0.03 for cardiogenic shock, P=0.19 for septic shock, and P=0.84 for hypovolemic shock, in Kaplan-Meier analyses). CONCLUSIONS: Although there was no significant difference in the rate of death between patients with shock who were treated with dopamine as the first-line vasopressor agent and those who were treated with norepinephrine, the use of dopamine was associated with a greater number of adverse events. (ClinicalTrials.gov number, NCT00314704.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Dopamine (DA) is a neurotransmitter in the catechol family, which is often used as first-line vasoactive drug in patients with septic shock (43).”
From Dopamine Is a Siderophore-Like Iron Chelator That Promotes Salmonella enterica Serovar Typhimurium Virulence in Mice (2019) · cites this paper as [43]
Citations
Cites
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Self-citationWriting Committee Members, Antman, E. M., Anbe, D. T., Armstrong, P. W., Bates, E. R., Green, L. A., Hand, M., Hochman, J. S., Krumholz, H. M., Kushner, F. G., et al. (2004) · Circulation · doi:10.1161/01.cir.0000134791.68010.fa · Cited by 8,356
Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R., et al. (2008) · Intensive Care Medicine · doi:10.1007/s00134-007-0934-2 · Cited by 6,772
Self-citationCDC definitions for nosocomial infections, 1988
Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C., & Hughes, J. M. (1988) · American Journal of Infection Control · doi:10.1016/0196-6553(88)90053-3 · Cited by 5,672
CDC definitions for nosocomial infections
Yangco, B. G. (1989) · American Journal of Infection Control · doi:10.1016/s0196-6553(89)80013-6 · Cited by 3,770
Annane, D. (2002) · JAMA · doi:10.1001/jama.288.7.862 · Cited by 3,087
Treating Patients with Severe Sepsis
Wheeler, A. P., & Bernard, G. R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901213400307 · Cited by 992
Current Epidemiology of Septic Shock: The CUB-Réa Network
Annane, D., Aegerter, P., Jars-Guincestre, M. C., & Guidet, B. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2201087 · Cited by 637
Research works printed but not linked: 1
- Mullner M, 2004, Cochrane Database Syst Rev, 3, CD003709
Cited by
Items 301–400 of 1,000
Pulmonary Hypertension and Right Ventricular Failure in Emergency Medicine
Wilcox, S. R., Kabrhel, C., & Channick, R. N. (2015) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2015.07.525 · Cited by 68
Oleskin, A. V., Ba, S., & Rogovskii, V. (2017) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-017-9262-1 · Cited by 68
JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure
Kitai, T., Kohsaka, S., Kato, T., Kato, E. T., Sato, K., TERAMOTO, K., Yaku, H., Akiyama, E., Ando, M., Izumi, C., et al. (2025) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2025.02.014 · Cited by 68
Belletti, A., Musu, M., Silvetti, S., Saleh, O., Pasin, L., Monaco, F., Hajjar, L. A., Fominskiy, E. V., Finco, G., Zangrillo, A., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142605 · Cited by 67
“Despiteimprove- mentinpathophysiologyunderstandingandtherapeuticmanagement,mortalityassociated withshockremainsashighas50%,andrefractorycardiovascularfailureisamajorcauseof deathintheICUs[5,42,43].”
BackgroundInfluentialHajjar, L. A., Zambolim, C. M., Belletti, A., de Almeida, J. P., Gordon, A. C., Oliveira, G., Park, C. H. L., Fukushima, J. T., Rizk, S. I., Szeles, T. F., et al. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000004023 · Cited by 67
The Surviving Sepsis Campaign Guidelines 2012: Update for Emergency Physicians
Jones, A. E., & Puskarich, M. A. (2013) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2013.08.004 · Cited by 66
“A recent large randomized trial comparing dopamine with norepinephrine for the treatment of shock found that dopamine was associated with an increased risk of adverse events, particularly tachydysrhythmias, even though no clear mortality difference between the 2 vasopressors was found overall; however, the study did f…”
Jeyaraju, M., McCurdy, M. T., Levine, A. R., Devarajan, P., Mazzeffi, M. A., Mullins, K. E., Reif, M., Yim, D. N., Parrino, C. R., Lankford, A. S., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005143 · Cited by 66
Medical Therapy of Cardiogenic Shock: Contemporary Use of Inotropes and Vasopressors
Riccardi, M., Pagnesi, M., Chioncel, O. D., Mebazaa, A., Cotter, G., Gustafsson, F., Tomasoni, D., Latronico, N., Adamo, M., & Metra, M. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3162 · Cited by 66
Chinese Guidelines for the Diagnosis and Treatment of Heart Failure 2024
ZHANG, S.-Y. (2025) · 老年心脏病学杂志:英文版 · doi:10.26599/1671-5411.2025.03.002 · Cited by 70
How Outcomes Are Defined in Clinical Trials of Mechanically Ventilated Adults and Children
Blackwood, B., Clarke, M. J., McAuley, D. F., McGuigan, P. J., Marshall, J. C., & Rose, L. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201309-1645pp · Cited by 66
“Day 1(50, 54) Day 28(24, 31, 45, 50, 52, 58, 65, 66, 68-70, 76) Intubation(50) Day 60(24) Randomization (24, 30, 40, 46, 49, 51, 52, 81) Day 90(57) Not specifically stated(26, 65, 69, 70, 76) Day 28 and 90(54) Not specifically stated(72)”
BackgroundVasopressors and Inotropes in Sepsis
Stratton, L., Berlin, D., & Arbo, J. E. (2016) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2016.09.005 · Cited by 66
“Notably, the median dopamine doses for all patients over the first 7 days fell within the medium to high dose range, but did not exceed 17 mg/kg/min.(55)”
BackgroundInfluentialYang, J. H., Choi, K. H., Ko, Y., Ahn, C., Yu, C. W., Chun, W. J., Jang, W. J., Kim, H., Kim, B. S., Bae, J., et al. (2021) · Circulation Heart Failure · doi:10.1161/circheartfailure.120.008141 · Cited by 65
A Clinical Update on Vasoactive Medication in the Management of Cardiogenic Shock
Shankar, A., Gurumurthy, G., Sridharan, L., Gupta, D., Nicholson, W. J., Jaber, W. A., & Vallabhajosyula, S. (2022) · Clinical Medicine Insights Cardiology · doi:10.1177/11795468221075064 · Cited by 65
Goodson, C. M., Rosenblatt, K. R., Rivera‐Lara, L., Nyquist, P., & Hogue, C. W. J. (2016) · Journal of Intensive Care Medicine · doi:10.1177/0885066616673973 · Cited by 66
Review article: Acute kidney injury in critical illness
Bagshaw, S. M., Bellomo, R., Devarajan, P., Johnson, C., Karvellas, C. J., Kutsogiannis, D. J., Mehta, R. L., Pannu, N., Romanovsky, A. S., Sheinfeld, G. R., et al. (2010) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-010-9375-4 · Cited by 65
Vincent, J., Pereira, A. J., Gleeson, P. J., & Backer, D. D. (2014) · Clinical and Experimental Emergency Medicine · doi:10.15441/ceem.14.005 · Cited by 65
“Norepinephrine is the vasopressor of choice (grade 1B) because dopamine has been associated with increased adverse effects in patients with shock and higher mortality rates than norepinephrine in patients with septic shock.(28,29) Low doses of dobutamine (about 5 mcg/kg/min) are often added to norepinephrine to increa…”
BackgroundSelf-citationWu, M., Ghassemi, M., Feng, M., Celi, L. A., Szolovits, P., & Doshi-Velez, F. (2017) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocw138 · Cited by 50
“A multicenter randomized trial comparing the use of dopamine or norepinephrine as first-line vasopressor therapy in 1679 patients with shock found that patients treated with dopamine had significantly more arrhythmic events.(29) We could also improve the prediction quality of our model with additional features, such a…”
Unverzagt, S., Wachsmuth, L., Hirsch, K., Thiele, H., Buerke, M., Haerting, J., Werdan, K., & Prondzinsky, R. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009669.pub2 · Cited by 63
Vasopressors in septic shock: a systematic review and network meta-analysis
Zhou, F., Mao, Z., Zeng, X.-T., Kang, H., Liu, H., Pan, L., & Hou, P. C. (2015) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s80060 · Cited by 56
Pirracchio, R., Pařenica, J., Resche‐Rigon, M., Chevret, S., Špinar, J., Jarkovský, J., Zannad, F. M., Alla, F., Mebazaa, A., & for the GREAT network (2013) · PLoS ONE · doi:10.1371/journal.pone.0071659 · Cited by 63
“[27] would suggest that inopressors, such as norepinephrine, might be necessary in severe patients, but the addition of a vasodilator might be beneficial.”
BackgroundInfluentialIdentification of Cardiac Dysfunction in Sepsis with B-Type Natriuretic Peptide
Turner, K. L., Moore, L. J., Todd, R. S., Sucher, J. F., Jones, S. A., McKinley, B. A., Valdivia, A., Sailors, M. R., & Moore, F. A. (2011) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2011.03.027 · Cited by 63
Etiology of Shock in the Emergency Department: A 12-Year Population-Based Cohort Study
Holler, J. G., Kildegaard, H., Henriksen, D. P., Rasmussen, L. M., Mikkelsen, S. S., Pedersen, C., & Lassen, A. T. (2016) · Shock · doi:10.1097/shk.0000000000000816 · Cited by 63
Thirty years of critical care medicine
Vincent, J., Singer, M., Marini, J. J., Moreno, R. P., Levy, M. M., Matthay, M. A., Pinsky, M. R., Rhodes, A., Ferguson, N. D., Evans, T. W., et al. (2010) · Critical Care · doi:10.1186/cc8979 · Cited by 63
“Studies have been conducted to evaluate issues of ongoing uncertainty, such as the safety of albumin [15], the pulmonary artery catheter [16], and dopamine as a fi rst-line agent in shock [17], providing important infor mation on some of the many aspects of clinical practice which are widely used but unproven.”
MethodSelf-citationSepsis, Severe Sepsis, and Septic Shock
Munford, R. S., & Suffredini, A. F. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00070-9 · Cited by 63
Delmas, C., Puymirat, É., Leurent, G., Elbaz, M., Manzo‐Silberman, S., Bonello, L., Gerbaud, É., Bataille, V., Lévy, B., Lamblin, N., et al. (2019) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2019.02.001 · Cited by 62
“These contrast with weak recommendations regarding the use of catecholamines in the management of CS, in the absence of large dedicated randomized studies [7-9].”
BackgroundConsenso para la mejora de la atención integral a los pacientes con insuficiencia cardiaca aguda
Llorens, P., Lorite, N. M., Manzano, L., Martín-Sánchez, F., Colet, J. C., Formiga, F., Jacob, J., Delgado, J. F., Montero-Pérez-Barquero, M., Herrero, P., et al. (2015) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) · Cited by 62
Heart Failure After Right Ventricular Myocardial Infarction
Nägele, M. P., & Flammer, A. J. (2022) · Current Heart Failure Reports · doi:10.1007/s11897-022-00577-8 · Cited by 62
Contemporary approach to cardiogenic shock care: a state-of-the-art review
Mehta, A., Vavilin, I., Nguyen, A. H., Batchelor, W., Blumer, V. L., Cilia, L. A., Dewanjee, A., Desai, M., Desai, S., Flanagan, M. C., et al. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1354158 · Cited by 62
Tubaro, M., Danchin, N., Goldstein, P., Filippatos, G. S., Hasin, Y., Heras, M., Janský, P., Norekvål, T. M., Swahn, E., Thygesen, K. A., et al. (2011) · Acute Cardiac Care · doi:10.3109/17482941.2011.581292 · Cited by 62
Drug utilization pattern in critical care unit in a tertiary care teaching hospital in India
Tripathi, C., Patel, M., Barvaliya, M. J., & Patel, T. K. (2013) · International Journal of Critical Illness and Injury Science · doi:10.4103/2229-5151.124128 · Cited by 62
“However, use of dopamine is associated with cardiac arrhythmia.[16]”
Emergency Department Management of Pediatric Shock
Mendelson, J. (2018) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2017.12.010 · Cited by 62
Loehn, T., O’Neill, W. W., Lange, B., Pfluecke, C., Schweigler, T., Mierke, J., Waessnig, N. K., Mahlmann, A., Youssef, A. A., Speiser, U., et al. (2018) · European Heart Journal Acute Cardiovascular Care · doi:10.1177/2048872618815063 · Cited by 62
Liver Transplantation in Acute-on-chronic Liver Failure
Karvellas, C. J., Francoz, C., & Weiss, E. (2020) · Transplantation · doi:10.1097/tp.0000000000003550 · Cited by 62
“Norepinephrine is advocated as first-line vasopressor due to its association with lower rates of side effects.(34) Vasopressin or terlipressin can be used in addition (second-line) and have demonstrated improvement in hemodynamics in cirrhotic patients.”
BackgroundWerdan, K., & Ruß, M. (2011) · Intensivmedizin und Notfallmedizin · doi:10.1007/s00390-011-0313-7 · Cited by 62
Møller, M. H., Claudius, C., Junttila, E., Haney, M., Oscarsson‐Tibblin, A., Haavind, A., & Perner, A. (2016) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.12780 · Cited by 61
“However, the rate of death at 28 days was significantly higher among patients with cardiogenic shock who were treated with dopamine than among those treated with norepinephrine (Table S3A).(10) No other outcome measures of interest have been assessed.”
BackgroundPrevention and Therapy of Acute Kidney Injury in the Developing World
Kher, V., Srisawat, N., Noiri, E., Gharbi, M. B., Shetty, M. S., Yang, L., Bagga, A., Chakravarthi, R. M., & Mehta, R. L. (2017) · Kidney International Reports · doi:10.1016/j.ekir.2017.03.015 · Cited by 61
“A study that compared the efficacy between norepinephrine and dopamine did not show any difference in mortality and AKI incidence between the groups.(46) However, the use of dopamine was associated with more adverse events, such as cardiac arrhythmia in the”
BackgroundResultLewis, T. C., Aberle, C., Altshuler, D., Piper, G. L., & Papadopoulos, J. (2018) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248418797357 · Cited by 61
Midodrine for the weaning of vasopressor infusions
Poveromo, L. B., Michalets, E. L., & Sutherland, S. E. (2016) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12375 · Cited by 60
Emergency Neurological Life Support: Traumatic Spine Injury
Stein, D. M., Roddy, V., Marx, J. A., Smith, W. S., & Weingart, S. D. (2012) · Neurocritical Care · doi:10.1007/s12028-012-9759-0 · Cited by 60
Clinical examination for diagnosing circulatory shock
Hiemstra, B., Eck, R. J., Keus, F., & van der Horst, I. C. C. (2017) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000420 · Cited by 59
“INTRODUCTION Many critically ill patients suffer from circulatory shock, which places them at increased risks of multiorgan failure, long-term morbidity and mortality [1,2].”
Effects of Inotropes on the Mortality in Patients With Septic Shock
Sato, R., Ariyoshi, N., Hasegawa, D., Crossey, E., Hamahata, N. T., Ishihara, T., Nasu, M., & Devendra, G. (2019) · Journal of Intensive Care Medicine · doi:10.1177/0885066619892218 · Cited by 59
Tewelde, S. Z., Liu, S. S., & Winters, M. E. (2017) · Cardiology Clinics · doi:10.1016/j.ccl.2017.08.009 · Cited by 59
COVID-19 and the cardiovascular system: an update
Salabei, J. K., Asnake, Z. T., Ismail, Z. H., Charles, K., Stanger, G., Abdullahi, A. H., Abraham, A. T., & Okonoboh, P. (2022) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2022.01.022 · Cited by 58
“Dobutamine Cardiogenic shock Decompensated HF Bradycardia Usual dosing range is 2 20 mcg/kg/min + +++++ +++ N/A N/A N/A According to AHA and ACCF, doses >20 mcg/ kg/min are not recommended in heart failure Tachycardia, PVCs, and angina pectoris Pheochromocytoma and tachyarrhythmias.(93)”
Differential signaling in presynaptic neurotransmitter release
Ghijsen, W. E. J. M., & Leenders, A. G. M. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4525-0 · Cited by 58
Epidemiology of Vasopressin Use for Adults with Septic Shock
Vail, E. A., Gershengorn, H. B., Hua, M. S., Walkey, A. J., & Wunsch, H. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201604-259oc · Cited by 58
Russell, J. A., Lee, T., Singer, J., Backer, D. D., & Annane, D. (2018) · Journal of Critical Care · doi:10.1016/j.jcrc.2018.05.003 · Cited by 58
Ham, K. R., Boldt, D. W., McCurdy, M. T., Busse, L. W., Favory, R., Gong, M. N., Khanna, A. K., Chock, S., Zeng, F., Chawla, L. S., et al. (2019) · Annals of Intensive Care · doi:10.1186/s13613-019-0536-5 · Cited by 57
Optimal Perfusion Targets in Cardiogenic Shock
Mathew, R., Fernando, S. M., Hu, K., Parlow, S., Santo, P. D., Brodie, D., & Hibbert, B. M. (2022) · JACC Advances · doi:10.1016/j.jacadv.2022.100034 · Cited by 57
Mean perfusion pressure deficit during the initial management of shock—an observational cohort study
Panwar, R., Lanyon, N., Davies, A. R., Bailey, M., Pilcher, D. V., & Bellomo, R. (2013) · Journal of Critical Care · doi:10.1016/j.jcrc.2013.05.009 · Cited by 57
Kirkegaard, H., Taccone, F. S., Skrifvars, M. B., & Søreide, E. (2019) · Anesthesiology · doi:10.1097/aln.0000000000002700 · Cited by 57
Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices
Chieffo, A., Dudek, D., Hassager, C., Combes, A., Gramegna, M., Halvorsen, S., Huber, K., Kunadian, V., Malý, J., Møller, J. E., et al. (2021) · EuroIntervention · doi:10.4244/eijy21m05_01 · Cited by 57
“Although vasopressin significantly increases mean arterial pressure (MAP), it has a lesser effect on cardiac index compared to norepinephrine.(91,92) Its theoretical advantage at low dose (pulmonary vasoconstriction) deserves further investigation.”
Background2020 Clinical practice guidelines for Myocarditis in adults
Arutyunov, G. P., Палеев, Ф. Н., Моисеева, О. М., Драгунов, Д. О., Sokolova, A. V., Arutyunov, A. G., Жиров, И. В., Blagova, O. V., Privalova, E. V., Габрусенко, С. А., et al. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4790 · Cited by 56
Møller, J. E., Sionís, A., Aïssaoui, N., Ariza, A., Bělohlávek, J., Backer, D. D., Färber, G., Gollmann‐Tepeköylü, C., Mebazaa, A., Price, S., et al. (2023) · European Heart Journal Acute Cardiovascular Care · doi:10.1093/ehjacc/zuad064 · Cited by 56
Strategies to prevent or reduce acute and chronic kidney injury in liver transplantation
Saner, F. H., Cicinnati, V. R., Sotiropoulos, G. C., & Beckebaum, S. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02563.x · Cited by 56
“In a recent prospective randomized large multicentre trial, the effect of dopamine was compared with norepinephrine in septic patients (56).”
BackgroundOutcome of elderly patients with circulatory failure
Biston, P., Aldecoa, C., Devriendt, J., Madl, C., Chochrad, D., Vincent, J., & Backer, D. D. (2013) · Intensive Care Medicine · doi:10.1007/s00134-013-3121-7 · Cited by 56
Self-citationHong, D., Choi, K. H., Cho, Y. H., Cho, S. H., Park, S. J., Kim, D., Park, T. K., Lee, J. M., Song, Y. B., Choi, J., et al. (2020) · Annals of Intensive Care · doi:10.1186/s13613-020-00701-8 · Cited by 56
Inotropes in cardiac patients: update 2011
Parissis, J., Rafouli‐Stergiou, P., Stassinos, V. E., Psarogiannakopoulos, P., & Mebazaa, A. (2010) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32833e10fb · Cited by 55
New medical therapies for heart failure
von Lueder, T. G., & Krum, H. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.137 · Cited by 55
Busse, L. W., McCurdy, M. T., Ali, O., Hall, A., Chen, H., & Ostermann, M. (2017) · Critical Care · doi:10.1186/s13054-017-1896-6 · Cited by 55
Lesur, O., Delile, E., Asfar, P., & Radermacher, P. (2018) · Annals of Intensive Care · doi:10.1186/s13613-018-0449-8 · Cited by 56
Naik, T. S. S. K., Mwaurah, M. M., & Swamy, B. E. K. (2018) · Journal of Electroanalytical Chemistry · doi:10.1016/j.jelechem.2018.12.054 · Cited by 55
The Surviving Sepsis Campaign: Where have we been and where are we going?
Dellinger, R. P. (2015) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.82gr.15001 · Cited by 55
Emergency Neurological Life Support: Traumatic Spine Injury
Stein, D. M., & Knight, W. A. (2017) · Neurocritical Care · doi:10.1007/s12028-017-0462-z · Cited by 55
van Diepen, S., Pöss, J., Senaratne, J. M., Gage, A., & Morrow, D. A. (2024) · Circulation · doi:10.1161/circulationaha.124.069508 · Cited by 54
Vasopressor and Inotropic Management Of Patients With Septic Shock.
Pollard, S. R., Edwin, S. B., & Alaniz, C. (2015) · PubMed · Cited by 54
Pulmonary Hypertension in the Intensive Care Unit
Jentzer, J. C., & Mathier, M. A. (2015) · Journal of Intensive Care Medicine · doi:10.1177/0885066615583652 · Cited by 54
“Dopamine can be useful for vasopressor support due to its positive inotropic effects, despite an increased risk of tachyarrhythmias and less effective MAP augmentation than norepinephrine.(6,27,29,32,78) Epinephrine can effectively raise MAP and support RV inotropy but often produces tachycardia, arrhythmias, and lact…”
BackgroundTemporal trends in the utilization of vasopressors in intensive care units: an epidemiologic study
Thongprayoon, C., Cheungpasitporn, W., Harrison, A. M., Carrera, P., Srivali, N., Kittamongkolchai, W., Erdoğan, A., & KASHANI, K. B. (2016) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-016-0063-z · Cited by 54
“In 2010, a multicenter randomized trial subgroup analysis demonstrated that patients with cardiogenic shock who received dopamine had a higher mortality compared to norepinephrine [14].”
BackgroundMethodIntensity of Vasopressor Therapy for Septic Shock and the Risk of In-Hospital Death
Brand, D. A., Patrick, P. A., Berger, J. T., Ibrahim, M., Matela, A., Upadhyay, S., & Spiegler, P. A. (2017) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2016.12.333 · Cited by 54
Efficacy and Safety of the Early Addition of Vasopressin to Norepinephrine in Septic Shock
Hammond, D. A., Cullen, J., Painter, J. T., McCain, K., Clem, O. A., Brotherton, A. L., Chopra, D., & Meena, N. K. (2017) · Journal of Intensive Care Medicine · doi:10.1177/0885066617725255 · Cited by 54
Transplantation, bridging, and support technologies in pulmonary hypertension
Savale, L., Benazzo, A., Corris, P. A., Keshavjee, S. H., Levine, D. J., Mercier, O. M., Davis, R. D., & Granton, J. T. (2024) · European Respiratory Journal · doi:10.1183/13993003.01193-2024 · Cited by 53
“They should be used with caution in patients with PH. Dopamine could be another potential alternative of dobutamine; however, its use is limited by a higher risk of arrhythmic events [31].”
Oh, H. J., Shin, D., Lee, M. J., Koo, H. M., Doh, F. M., Kim, H. R., Han, J. H., Park, J. T., Han, S. H., Yoo, T., et al. (2012) · Journal of Critical Care · doi:10.1016/j.jcrc.2012.08.001 · Cited by 53
“Although there is no definitive evidence of the superiority of one vasopressor over another in severe septic shock [11], norepinephrine was preferred in most patients according to our ICU policy.”
BackgroundDelbove, A., Darreau, C., Hamel, J. F., Asfar, P., & Lerolle, N. (2015) · Journal of Critical Care · doi:10.1016/j.jcrc.2015.08.018 · Cited by 53
Powering Bias and Clinically Important Treatment Effects in Randomized Trials of Critical Illness*
Abrams, D. C., Montesi, S. B., Moore, S. K., Manson, D. K., Klipper, K. M., Case, M. A., Brodie, D., & Beitler, J. R. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004568 · Cited by 53
Sarma, D., & Jentzer, J. C. (2023) · Critical Care Clinics · doi:10.1016/j.ccc.2023.05.001 · Cited by 52
Pathophysiology, diagnosis, and treatment of infarction-related cardiogenic shock
Buerke, M., Lemm, H., Dietz, S., & Werdan, K. (2011) · Herz · doi:10.1007/s00059-011-3434-7 · Cited by 52
Oba, Y., & Lone, N. (2014) · Journal of Critical Care · doi:10.1016/j.jcrc.2014.04.011 · Cited by 52
“Data of patientswith septic shock were extracted from a trial including patients with septic together with other types of shock [19].”
BackgroundMethodThe Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
Shime, N., Nakada, T.-A., Yatabe, T., Yamakawa, K., Aoki, Y., Inoue, S., Iba, T., Ogura, H., Kawai, Y., Kawaguchi, A., et al. (2025) · Journal of Intensive Care · doi:10.1186/s40560-025-00776-0 · Cited by 52
Cheng, L., Yan, J., Han, S., Chen, Q., Chen, M., Jiang, H., & Lü, J. (2019) · Critical Care · doi:10.1186/s13054-019-2427-4 · Cited by 52
Nanchal, R. S., & Ahmad, S. (2016) · Critical Care Clinics · doi:10.1016/j.ccc.2016.03.006 · Cited by 51
Dichtl, S., Demetz, E., Haschka, D., Tymoszuk, P., Petzer, V., Nairz, M., Seifert, M., Hoffmann, A., Brigo, N., Würzner, R., et al. (2019) · mBio · doi:10.1128/mbio.02624-18 · Cited by 50
Right Ventricular Myocardial Infarction—A Tale of Two Ventricles
Goldstein, J. A., Lerakis, S., & Moreno, P. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.09.839 · Cited by 50
Udesen, N. L. J., Beske, R. P., Hassager, C., Jensen, L. O., Eiskjær, H., Mangner, N., Polzin, A., Schulze, P. C., Skurk, C., Nordbeck, P., et al. (2024) · JAMA Cardiology · doi:10.1001/jamacardio.2024.4197 · Cited by 50
Chinese Guidelines for the Diagnosis and Treatment of Heart Failure 2024
Chinese Society of Cardiology, C. M. A., Chinese College of Cardiovascular Physician, Chinese Heart Failure Association of Chinese Medical Doctor Association, & Editorial Board of Chinese Journal of Cardiology (2025) · Cardiology Discovery · doi:10.1097/cd9.0000000000000146 · Cited by 50
Estimating attributable fraction of mortality from sepsis to inform clinical trials
Shankar‐Hari, M., Harrison, D. A., Rowan, K., & Rubenfeld, G. D. (2018) · Journal of Critical Care · doi:10.1016/j.jcrc.2018.01.018 · Cited by 49
“For sepsis cases and non- septic critically ill controls, we used the Intensive Care National Audit & Research Centre (ICNARC) Case Mix Programme Database (CMPD) [19] (Further details are reported in eMethods).”
MethodInfluentialUse of Levosimendan in Intensive Care Unit Settings: An Opinion Paper
Herpain, A., Bouchez, S., Girardis, M., Guarracino, F., Knotzer, H., Lévy, B., Liebregts, T., Pollesello, P., Ricksten, S., Říha, H., et al. (2018) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000636 · Cited by 49
Lat, I., Coopersmith, C. M., & Backer, D. D. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000004864 · Cited by 49
Use of Mechanical Circulatory Support in Patients with Non-Ischaemic Cardiogenic Shock
Schrage, B., Sundermeyer, J., Beer, B. N., Bertoldi, L. F., Bernhardt, A. M. J., Blankenberg, S., Dauw, J., Dindane, Z., Eckner, D., Eitel, I., et al. (2023) · European Journal of Heart Failure · doi:10.1002/ejhf.2796 · Cited by 49
Section 3: Prevention and Treatment of AKI
(2012) · Kidney International Supplements · doi:10.1038/kisup.2011.33 · Cited by 49
Sepsis, severe sepsis, and septic shock: A review of the literature
Tupchong, K., Koyfman, A., & Foran, M. P. (2014) · African Journal of Emergency Medicine · doi:10.1016/j.afjem.2014.05.004 · Cited by 48
Karami, M., Hemradj, V. V., Ouweneel, D. M., den Uil, C. A., Limpens, J., Otterspoor, L., Vlaar, A. P. J., Lagrand, W. K., & Henriques, J. P. S. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072051 · Cited by 48
“) reporting a lower rate of arrhythmias and a trend toward lower mortality compared with dopamine in a subgroup analysis [16].”
BackgroundJaramillo, R. P. (2020) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2020.07.026 · Cited by 48
Lat, I., Coopersmith, C. M., Backer, D. D., & Coopersmith, C. M. (2021) · Intensive Care Medicine Experimental · doi:10.1186/s40635-021-00369-9 · Cited by 48
Norepinephrine in Septic Shock: A Systematic Review and Meta-analysis
bin Ruslan, M. R., Baharuddin, K. A., Norhayati, M. N., Yazid, M., Noh, A. Y. M., & Rahman, A. (2021) · Western Journal of Emergency Medicine · doi:10.5811/westjem.2020.10.47825 · Cited by 48
Evaluation and Management of Shock States: Hypovolemic, Distributive, and Cardiogenic Shock
Moranville, M. P., Mieure, K. D., & Santayana, E. M. (2010) · Journal of Pharmacy Practice · doi:10.1177/0897190010388150 · Cited by 50
“This was a post hoc, subgroup analysis and the study was not powered to detect such a difference.(150) Clinicians should keep in mind the risk of using potent vasoconstricting agents, such as norepinephrine (Table 5), which can significantly increase SVR in patients with already poor cardiac contractility.”
Improving Outcomes from Out-of-Hospital Cardiac Arrest in Young Children and Adolescents
Atkins, D. L., & Berger, S. (2011) · Pediatric Cardiology · doi:10.1007/s00246-011-0084-8 · Cited by 48
“Studies performed in animals [23, 45, 60], pediatric postoperative heart patients [39, 40], or those with septic shock [23] have demonstrated hemodynamic improvement with a variety of drugs.”
BackgroundCritical care management of hantavirus cardiopulmonary syndrome. A narrative review
Ulloa-Morrison, R., Pavez, N., Parra, E., López, R., Mondaca, R., Fernandez, P., Kraunik, D., Sanhueza, C., Bravo, S., Cornú, M., et al. (2024) · Journal of Critical Care · doi:10.1016/j.jcrc.2024.154867 · Cited by 47
New Sepsis and Septic Shock Definitions
Rhee, C., & Klompas, M. (2017) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2017.05.001 · Cited by 47
Olson, J. C., & Karvellas, C. J. (2017) · Liver Transplantation · doi:10.1002/lt.24815 · Cited by 47
Capillary leak syndrome following snakebite envenomation
Udayabhaskaran, V., Thomas, E. T. A., & Shaji, B. (2017) · Indian Journal of Critical Care Medicine · doi:10.4103/ijccm.ijccm_41_17 · Cited by 47
Chow, J. H., Abuelkasem, E., Sankova, S. K., Henderson, R. A., Mazzeffi, M. A., & Tanaka, K. A. (2019) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000004343 · Cited by 48
Metadata
- Authors
- De Backer, D., Biston, P., Devriendt, J., Madl, C., Chochrad, D., Aldecoa, C., Brasseur, A., Defrance, P., Gottignies, P., & Vincent, J.-L.
- Affiliations
- Université Libre de Bruxelles (BE)
- Medical University of Vienna (AT)
- Centre hospitalier Etterbeek-Ixelles (BE)
- Erasmus Hospital (BE)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-03-04
- Volume
- 362
- Issue
- 9
- Pages
- 779-789
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2095944485
- Cited by
- 1,940
- References
- 31
- Citations by year
- 2026: 98 · 2025: 107 · 2024: 140 · 2023: 115 · 2022: 125 · 2021: 132 · 2020: 135 · 2019: 138 · 2018: 106 · 2017: 139 · 2016: 99 · 2015: 122 · 2014: 120 · 2013: 96 · 2012: 110
- FWCI
- 83.32
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Trauma, Hemostasis, Coagulopathy, Resuscitation
- Keywords
- dopamine, norepinephrine, vasopressors, shock, cardiogenic shock, septic shock, hypovolemic shock, 28-day mortality, cardiac arrhythmias, epinephrine, vasopressin, organ support, adverse events, subgroup analysis, vasopressor weaning
- MeSH terms
- Aged, Arrhythmias, Cardiac, Combined Modality Therapy, Dopamine, Female, Fluid Therapy, Humans, Male, Middle Aged, Norepinephrine, Shock, Vasoconstrictor Agents, Kaplan-Meier Estimate, Intention to Treat Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.